热门资讯> 正文
Theriva Biologics申请普通股发行
2024-09-11 05:19
- Theriva Biologics (NYSE:TOVX) filed preliminary prospectus for offering of up to about 2.2M shares of common stock, together with warrants to purchase up to 2.2M shares of common stock.
- SEC Filing
More on Theriva Biologics
- Seeking Alpha’s Quant Rating on Theriva Biologics
- Historical earnings data for Theriva Biologics
- Financial information for Theriva Biologics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。